Partnership Opportunities

Our goal is to create partnerships with companies to help minimize their investment risk by providing the research environment, expertise, clinical samples and joint funding to conduct the preclinical and early-stage clinical research necessary to find treatments that would otherwise be ignored in the traditional for-profit, drug-development process. We see this as a revolutionary business model that will accelerate access to treatment for pediatric patients.

Potential partnerships are available in these areas:

Therapeutics

• ADHD
• Allergy and Asthma – Mast Cells
• Asthma and Lung Inflammation
• Autoimmune Diseases – Tregs
• Autoimmunity and Cancer
• Autoimmunity and Primary Immunodeficiency
• Autoimmunity – High-Specificity Targets
• Bone Disorders and Malformations
• Cancer – Cadherin-Mediated Interventions
• Cancer – Neuroblastoma
• Cerebellar Development
• Congenital Disorders of Glycosylation
• Craniofacial Malformations – Clinical Data
• Duchenne Muscular Dystrophy – Zebrafish Models
• Epilepsy and Other CNS Disorders
• Heart Metabolism and Function
• Hemophilia – Immunomodulation Therapy
• Hemophilia – Intraosseous Lentiviral Therapy
• HIV – CAR-T therapies
• HIV Microbiomes
• HIV – Viral Reservoirs
• Human Papillomavirus
• Infantile Hemangiomas and Other Vascular Malformations
• Inflammatory Bowel Disease--Cadherin-Mediated Interventions
• Inflammatory Bowel Disease--Dietary Modifications
• Juvenile Idiopathic Arthritis (JIA) and Juvenile Dermatomyositis (JDM) – Microbiome
• Kawasaki Disease
• Lupus - B-Cell Targets
• Lupus – T-Cell Targets
• Next-Generation Newborn Screening to Improve Treatment Efficacy
• Obesity
• Pain
• Retinal Disorders
• Wilson Disease and Other Lysosomal Storage Diseases--Newborn Screening

Diagnostics

• Autism – Characterizing Protein Interactions
• Cancer – Neuroblastoma
• Healthcare Associated Infections
• HIV – Viral Reservoirs
• Human Herpesvirus HHV-6 – Epidemiology
• Human Herpesvirus HHV-6 and HHV-7 Infections
• Human Papillomavirus
• Immune Dysregulation Syndromes
• Infantile Hemangiomas and Other Vascular Malformations
• Kawasaki Disease
• Lupus - B-Cell Targets
• Metabolic Disorders – Newborn Screening
• Mosaic Mutations
• Retinal Disorders
• Scleroderma
• Sepsis
• Sleep Apnea

Medical Devices

• Activity Trackers and Apps
• Craniofacial Malformations – Clinical Data
• Epilepsy – Medical Device Interventions
• Hemophilia – Gene Therapy
• Sleep Apnea

Vaccines

• Group B Streptococcus
• HIV Tissue Reservoirs
• Human Papillomavirus

Research Tools and Understanding Disease Pathways

• Addiction – Characterizing Pathways
• Allergy and Asthma – Mast Cells
• Anesthesia Risks
• Autism – Characterizing Protein Interactions
• Autism Genetic Pathways
• Autoimmunity and Cancer
• Autoimmunity and Primary Immunodeficiency
• Autoimmunity – High-Specificity Targets
• Asthma
• Asthma and Lung Inflammation
• Bone Disorders and Malformations
• Brain Overgrowth Diseases
• Brain Malformations
• Breathing Dysregulation
• Cancer – Cadherin-Mediated Interventions
• Cancer – Neuroblastoma
• Cerebellar Development
• Congenital Disorders of Glycosylation
• Craniofacial Birth Defects
• Dravet Syndrome – Advanced Animal Model
• Duchenne Muscular Dystrophy – Zebrafish Models
• Food Insecurity and Chronic Disease Management
• Healthcare Associated Infections
• Heart Metabolism and Function
• HIV Microbiomes
• HIV Tissue Reservoirs
• HIV – Viral Reservoirs
• Human Herpesvirus HHV-6 – Epidemiology
• Human Herpesvirus HHV-6 and HHV-7 Infections
• Human Papillomavirus
• Inflammatory Bowel Disease – Cadherin-Mediated Interventions
• Juvenile Idiopathic Arthritis (JIA) and Juvenile Dermatomyositis (JDM) – Microbiome
• Lupus - B-Cell Targets
• Metabolic Disorders – Newborn Screening
• Mitochondrial Disease
• Mosaic Mutations
• MRSA Infections
• Neuroregeneration
• Next-Generation Newborn Screening to Improve Treatment Efficacy
• Obesity
• Pregnancy Research – Biorepository
• Retinal Disorders
• Scleroderma
• Sepsis
• Sleep Apnea
• Small Animal Imaging
• Stroke
• Wilson Disease and Other Lysosomal Storage Diseases--Newborn Screening

Educational Products and Digital Health

• Activity and Fitness
• Activity Trackers and Apps
• ADHD
• Adolescent-Focused Digital Health Interventions
• Digital Health
• Inflammatory Bowel Disease – Cadherin-Mediated Interventions
• Optimizing Child Development
• Pain
• Sleep Science – Researching Child, Adolescent and Family Sleep  

Learn More

To learn more about partnering with Seattle Children’s Research Institute, or if you’re a Seattle Children’s researcher looking for industry partners. please contact:

Dr. Elizabeth Aylward
Director, Office of Science–Industry Partnerships
Email
206-844-1065